Dialysis world news


Combination therapy of renal cell carcinoma or breast cancer patients with ... - 7thSpace Interactive (press release) PDF Print
7thSpace Interactive (press release)
Ten cancer patients (Six renal cell carcinoma and four breast cancer patients) were treated in a phase I/II study with a vaccine composed of autologous dendritic cells (DCs) and IL-2 to evaluate the DC vaccine-related toxicity and antigen-specific

...

 
NAGICO Insurances donate to two community health-based institutions - ZIZ Live PDF Print
ZIZ Live
The St. Kitts Diabetes Association and the Nevis Renal Society each received a cheque of EC$1700 from NAGICO Insurances on Monday October 19 at a function held at the ZIZ Television studios at Springfield in Basseterre. “It was the first time in the

...

 
Baxter Resolves Issues At Puerto Rico, Ireland Plants - Wall Street Journal PDF Print
Wall Street Journal
Problems in Ireland arose in late 2010 when endotoxins, which are harmful substances released from bacteria, were found in peritoneal dialysis solutions made at Baxter's plant in Castlebar. Baxter temporarily shut down manufacturing at the plant to

...

 
Research Park Company Receives Canadian Patent - Inside INdiana Business (press release) PDF Print
Inside INdiana Business (press release)
A Purdue Research Park-based company has been awarded a Canadian patent for new dialysis technology. Vasc-Alert LLC's device monitors patients for a specific complication. West Lafayette, Ind., and Detroit - Technology that helps dialysis providers

...

 
Drug-Eluting Stents Safe for Most Older CKD Patients - Renal and Urology News PDF Print
Renal and Urology News
Drug-eluting stents are safe to use in older patients undergoing percutaneous coronary interventions regardless of renal function, researchers concluded. In addition, use of these stents are associated with lower risks of death and myocardial

...

 
<< Start < Prev 631 632 633 634 635 636 637 638 639 640 Next > End >>

Page 637 of 2630
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.